Research News
View articles by month and year
-
AMA Updates Mammogram Policy, Says Screening Should Start at 40
The American Medical Association's new policy says that all women should be eligible for screening mammograms starting at age 40 and that all insurance plans should cover the cost of the screening.
-
Another Study Suggests Night Work Raises Risk
A French study has found that women who worked the night shift were 35% more likely to be diagnosed with breast cancer compared to women who never worked night shifts.
-
Breast Cancer’s Hormone Receptor and HER2 Status Can Change After Diagnosis
The characteristics of a breast cancer -- including hormone receptor status and HER2 status -- can change over time. These changes may happen because the cancer cells change themselves or because treat...
-
Circulating Tumor Cells Linked to Worse Prognosis in Early-Stage Disease
A study has found that circulating tumor cells in the bloodstream are linked to worse prognosis in people diagnosed with early-stage breast cancer.
-
Diabetes Medicine Linked to Lower Risk
A large study has found that diabetic women taking the medicine metformin had a lower-than-average-risk of breast cancer.
-
FDA Approves Perjeta for Metastatic, HER2-Positive Disease
The FDA has approved using Perjeta (chemical name: pertuzumab) in combination with Herceptin and Taxotere to treat HER2-positive, metastatic breast cancer that hasn't been treated with either Herceptin or chemotherapy yet.
-
Ginseng Helps Ease Treatment-Related Fatigue
A study has found ginseng capsules helped ease the fatigue that many people have during and after cancer treatment.
-
Cymbalta Helps Ease Neuropathy Caused by Chemo
A study has found that most people with peripheral neuropathy got some relief from the antidepressant medicine Cymbalta.
-
Radiation Therapy to Chest as Child Increases Breast Cancer Risk in Adulthood
A study found that women treated for childhood cancer with radiation therapy to the chest area have a much higher-than-average risk of breast cancer later in life; the risk is about the same as it is for women with an abnormal breast cancer gene.
-
MRI Better at Assessing Results of Chemo Before Surgery
Research shows that breast MRI before surgery is better at assessing how well a cancer responds to neoadjuvant treatment compared to more traditional assessment measures such as a physical exam, mammogram, or ultrasound.
